Tulane Research Innovation for Arrhythmia Discovery

Actively recruiting patients for EDORA Clinical Trial.

TRIAD

Latest News

TRIAD Heads to HRX 2026

TRIAD Heads to HRX 2026

With 9 abstracts accepted for presentation, TRIAD is gearing up for HRX 2026 this September. Our team will share its latest findings and join...

read more
HRS Meeting in Chicago 2026

HRS Meeting in Chicago 2026

TRIAD brought a strong scientific presence to Chicago, presenting 36 abstracts at Heart Rhythm 2026, the Heart Rhythm Society’s annual scientific...

read more

Publications

Pharmacological rhythm versus rate control in patients with atrial fibrillation and heart failure: the CASTLE-AF trial.

Zhao Y, Krupadev V, Dagher L, Mahnkopf C, Sohns C, Sehner S, Suling A, Sanders P, Boersma L, Schunkert H, Wegscheider K, Brachmann J, Marrouche NF.

J Interv Card Electrophysiol. 2020 Sep 4. doi: 10.1007/s10840-020-00856-1. Epub ahead of print. PMID: 32888121.

Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial.

Sohns C, Zintl K, Zhao Y, Dagher L, Andresen D, Siebels J, Wegscheider K, Sehner S, Boersma L, Merkely B, Pokushalov E, Sanders P, Schunkert H, Bänsch D, Mahnkopf C, Brachmann J, Marrouche NF.

Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008461. doi: 10.1161/CIRCEP.120.008461. Epub 2020 Sep 9. PMID: 32903044.

TRIAD

Clinical Research
Studies

Actively recruiting patients for WEAICOR study

TRIAD

Gallery